Earn CME credits at GMC!
HudsonAlpha will host the second Genomic Medicine Conference March 26-28, 2018 where practitioners will have the opportunity receive Continuing Medical Education (CME) credits. The Genomic Medicine Conference is an interdisciplinary and international program where physicians, researchers and other medical professionals will convene at the HudsonAlpha campus to discuss new findings, best practices, and challenges in the full implementation of genomics into clinical care.
2018: The Year of Genomic Medicine in Alabama
Alabama families seeking genomic testing will have more options than ever before in 2018, thanks to a number of new initiatives and research projects across the state. At HudsonAlpha Institute for Biotechnology alone, more than 1000 people have undergone diagnostic genomic sequencing in the last several years; in 2018, new and ongoing projects will push that number to 1500 or more.
GMC early bird registration rates extended!
You have another chance to save on the Genomic Medicine Conference registration fee. The early bird rate has been extended through Monday, January 15, 2018. To register for the conference and save on your registration fee,
Genome Gateway™ eases onboarding, offers education for patients, research participants
Orlando, Fla. – Genome Gateway™, a web-based software portal created by HudsonAlpha Institute for Biotechnology in Huntsville, Ala., was highlighted in a presentation at the American Society of Human Genetics (ASHG) annual meeting in Orlando. Genome Gateway™ manages interactions between genomic medicine patients and clinicians at the Smith Family Clinic for Genomic Medicine, also in Huntsville.
Front Line Genomics features the Hero Fund
Front Line Genomics, the media sponsor for this year’s Genomic Medicine Conference, highlighted the HudsonAlpha Hero Fund in the October issue of its magazine. The HudsonAlpha Foundation were discussing different options and fundraising proposals to help pay for sequencing for patients, when a surprise check for $1 million arrived, helping to establish the Hero Fund.
AGHI recognized as top collaboration in the southeast
Atlanta, Ga. – University of Alabama at Birmingham (UAB) Medicine and HudsonAlpha Institute for Biotechnology were recognized for their groundbreaking collaboration in genomics at the annual Health Connect South symposium in Atlanta, Ga. The Alabama Genomic Health Initiative (AGHI) was one of several collaborations aimed at improving health to be recognized at the event.
Tom May discusses challenges faced by adoptees who lack family health history
HudsonAlpha bioethicist Tom May, PhD, sat down with Your Health Radio to discuss the challenges faced by adoptees and others who don’t have access to their genetic relative’s health history. Your Health is a weekly one-hour radio talk show on patient health produced by the University of North Carolina Department of Family Medicine.
HudsonAlpha scientists explain how computer science is changing genomics
HudsonAlpha’s David Bick, MD; Candice Finnila, PhD; Molly Schroeder, PhD; and Liz Worthey, PhD, sat down with Alabama Public Television to discuss how computer scientists are changing the world of genetics and genomics.
Hero Fund brings hope to patients in need
HudsonAlpha Institute for Biotechnology is giving patients a chance at finding a diagnosis with the Hero Fund. Established by an anonymous donation to the HudsonAlpha Foundation, the Hero Fund helps patients at Smith Family Clinic for Genomic Medicine who need, but cannot afford, access to genomic medicine.
Alabama Genomic Health Initiative begins recruitment
Full scale recruitment for the Alabama Genomic Health Initiative (AGHI) has begun at University of Alabama at Birmingham clinics in Birmingham. The AGHI is one of the nation’s first statewide efforts to harness the power of genomic analysis to identify those at high risk for genetic disease.
HudsonAlpha CSER study results published in genome medicine
Since 2013, HudsonAlpha Institute for Biotechnology has led a large-scale DNA sequencing project to identify genetic variants that cause developmental delay in children. Results from the study are published online today in Genome Medicine along with a blog post by Greg Cooper, PhD, a HudsonAlpha faculty investigator who has provided leadership for the project:
The value of a diagnosis
The most common utility for whole genome sequencing currently is to diagnose unknown diseases, syndromic diseases or those diseases that manifest similarly to known disorders, but don’t respond well to traditional treatment. As clinical geneticist David Bick describes, these disorders are “three degrees of separation from what you expect.”
Genomics for the rest of us: HudsonAlpha introduces Insight Genome
The HudsonAlpha Institute for Biotechnology debuted a new program called Insight Genome in March 2017. Insight Genome decodes individuals’ DNA to look for answers that could help predict future health and help people make decisions about their care.